|
|
|
Insider
Information: |
Hooper Anthony C |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
618,962 |
|
Indirect Shares
|
5,248 |
|
|
Direct
Value |
$79,034,769 |
|
|
Indirect Value
|
$219,209 |
|
|
Total
Shares |
624,210 |
|
|
Total
Value |
$79,253,978 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
58.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
SVP ComOps Pres USJap ... |
2011-05-13 |
203,170 |
2011-05-13 |
5,248 |
Premium* |
|
Amgen Inc |
AMGN |
EVP, Global Commercial... |
2018-05-03 |
215,147 |
2011-10-27 |
0 |
Premium* |
|
MannKind Corp |
MNKD |
Director |
2024-02-04 |
176,153 |
|
0 |
Premium* |
|
Beigene Ltd |
BGNE |
Director |
2022-06-22 |
24,492 |
2021-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2017-01-30 |
4 |
D |
$157.16 |
$93,982 |
D/D |
(598) |
187,973 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2017-01-31 |
4 |
D |
$154.43 |
$103,159 |
D/D |
(668) |
187,305 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2017-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
23,092 |
210,397 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2017-03-24 |
4 |
D |
$166.04 |
$2,013,733 |
D/D |
(12,128) |
198,482 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,920 |
203,402 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2018-01-30 |
4 |
D |
$198.00 |
$113,850 |
D/D |
(575) |
203,134 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2018-01-31 |
4 |
D |
$191.27 |
$124,517 |
D/D |
(651) |
202,483 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2018-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,638 |
220,121 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2018-03-23 |
4 |
D |
$176.08 |
$1,550,737 |
D/D |
(8,807) |
211,522 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2018-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,508 |
216,030 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
|
2018-05-03 |
4 |
D |
$169.43 |
$149,607 |
D/D |
(883) |
215,147 |
0 |
- |
|
MNKD |
MannKind Corp |
Director |
|
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
30,048 |
126,201 |
0 |
- |
|
BGNE |
Beigene Ltd |
Director |
|
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,800 |
7,800 |
0 |
- |
|
MNKD |
MannKind Corp |
Director |
|
2022-02-28 |
4 |
B |
$2.71 |
$108,400 |
D/D |
40,000 |
338,394 |
2.39 |
% |
|
BGNE |
Beigene Ltd |
Director |
|
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,692 |
24,492 |
0 |
- |
|
MNKD |
MannKind Corp |
Director |
|
2024-02-04 |
4 |
A |
$3.27 |
$130,800 |
D/D |
40,000 |
176,153 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
President US Pharmaceuticals |
|
2007-09-10 |
4/A |
D |
$0.00 |
$0 |
D/D |
(3,882) |
104,547 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
President Americas |
|
2009-02-19 |
4/A |
D |
$20.51 |
$246,099 |
D/D |
(11,999) |
108,419 |
0 |
- |
|
93 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|